Effect of Hemoglobin on the Prognosis of Patients With Advanced Cancer in Palliative Care Settings
Background: Hemoglobin (Hb) has been reported as a prognostic factor in many cancer patients. However, its effect on the prognosis of patients with advanced cancer receiving palliative treatment is still unclear. Objective: The aim of this study was to assess whether Hb can be used as a prognostic i...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mary Ann Liebert
2024-10-01
|
| Series: | Palliative Medicine Reports |
| Subjects: | |
| Online Access: | https://www.liebertpub.com/doi/10.1089/pmr.2023.0041 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850030919757332480 |
|---|---|
| author | Xinghe Liao Cihang Bao Qi Song Hui Liu Minghui Liu Zhe Zhang Jin Zhang Chenyue Zhang Weiwei Zhao |
| author_facet | Xinghe Liao Cihang Bao Qi Song Hui Liu Minghui Liu Zhe Zhang Jin Zhang Chenyue Zhang Weiwei Zhao |
| author_sort | Xinghe Liao |
| collection | DOAJ |
| description | Background: Hemoglobin (Hb) has been reported as a prognostic factor in many cancer patients. However, its effect on the prognosis of patients with advanced cancer receiving palliative treatment is still unclear. Objective: The aim of this study was to assess whether Hb can be used as a prognostic indicator for patients with advanced cancer receiving palliative treatment. Methods: From July 2013 to October 2015, 368 consecutive patients were treated in the Palliative Treatment Center of Shanghai Cancer Center, Fudan University. The data of 105 patients were extended in the follow-up. The cutoff value selected for Hb was 100 g/L. Results: The median survival time of patients with low hemoglobin (LHb) was shorter than that of patients with high hemoglobin (HHb; 41 days vs. 84 days). In addition, in the follow-up readmission cohort (n = 105), the median survival time of patients with HHb (HHb → HHb) was 3.44 times longer than that of patients with LHb (HHb → LHb). To sum up, both LHb and descending Hb were identified as independent prognostic factors for poor prognosis. Conclusions: In palliative treatment, Hb can be used as a stratification factor to judge poor prognosis in advanced cancer patients. |
| format | Article |
| id | doaj-art-4e99bc378ec741bdb0af89c919bc904e |
| institution | DOAJ |
| issn | 2689-2820 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Mary Ann Liebert |
| record_format | Article |
| series | Palliative Medicine Reports |
| spelling | doaj-art-4e99bc378ec741bdb0af89c919bc904e2025-08-20T02:59:07ZengMary Ann LiebertPalliative Medicine Reports2689-28202024-10-015117718410.1089/pmr.2023.0041Effect of Hemoglobin on the Prognosis of Patients With Advanced Cancer in Palliative Care SettingsXinghe Liao0Cihang Bao1Qi Song2Hui Liu3Minghui Liu4Zhe Zhang5Jin Zhang6Chenyue Zhang7Weiwei Zhao8Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.Department of Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China.Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.Background: Hemoglobin (Hb) has been reported as a prognostic factor in many cancer patients. However, its effect on the prognosis of patients with advanced cancer receiving palliative treatment is still unclear. Objective: The aim of this study was to assess whether Hb can be used as a prognostic indicator for patients with advanced cancer receiving palliative treatment. Methods: From July 2013 to October 2015, 368 consecutive patients were treated in the Palliative Treatment Center of Shanghai Cancer Center, Fudan University. The data of 105 patients were extended in the follow-up. The cutoff value selected for Hb was 100 g/L. Results: The median survival time of patients with low hemoglobin (LHb) was shorter than that of patients with high hemoglobin (HHb; 41 days vs. 84 days). In addition, in the follow-up readmission cohort (n = 105), the median survival time of patients with HHb (HHb → HHb) was 3.44 times longer than that of patients with LHb (HHb → LHb). To sum up, both LHb and descending Hb were identified as independent prognostic factors for poor prognosis. Conclusions: In palliative treatment, Hb can be used as a stratification factor to judge poor prognosis in advanced cancer patients.https://www.liebertpub.com/doi/10.1089/pmr.2023.0041advanced cancerhemoglobinpalliative careprognostic value |
| spellingShingle | Xinghe Liao Cihang Bao Qi Song Hui Liu Minghui Liu Zhe Zhang Jin Zhang Chenyue Zhang Weiwei Zhao Effect of Hemoglobin on the Prognosis of Patients With Advanced Cancer in Palliative Care Settings Palliative Medicine Reports advanced cancer hemoglobin palliative care prognostic value |
| title | Effect of Hemoglobin on the Prognosis of Patients With Advanced Cancer in Palliative Care Settings |
| title_full | Effect of Hemoglobin on the Prognosis of Patients With Advanced Cancer in Palliative Care Settings |
| title_fullStr | Effect of Hemoglobin on the Prognosis of Patients With Advanced Cancer in Palliative Care Settings |
| title_full_unstemmed | Effect of Hemoglobin on the Prognosis of Patients With Advanced Cancer in Palliative Care Settings |
| title_short | Effect of Hemoglobin on the Prognosis of Patients With Advanced Cancer in Palliative Care Settings |
| title_sort | effect of hemoglobin on the prognosis of patients with advanced cancer in palliative care settings |
| topic | advanced cancer hemoglobin palliative care prognostic value |
| url | https://www.liebertpub.com/doi/10.1089/pmr.2023.0041 |
| work_keys_str_mv | AT xingheliao effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings AT cihangbao effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings AT qisong effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings AT huiliu effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings AT minghuiliu effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings AT zhezhang effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings AT jinzhang effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings AT chenyuezhang effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings AT weiweizhao effectofhemoglobinontheprognosisofpatientswithadvancedcancerinpalliativecaresettings |